0001179110-21-002815.txt : 20210303 0001179110-21-002815.hdr.sgml : 20210303 20210303201644 ACCESSION NUMBER: 0001179110-21-002815 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210301 FILED AS OF DATE: 20210303 DATE AS OF CHANGE: 20210303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Verstraete Stephany CENTRAL INDEX KEY: 0001726419 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 21711930 MAIL ADDRESS: STREET 1: C/O TELADOC, INC. STREET 2: 2 MANHATTANVILLE ROAD, SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 4 1 edgar.xml FORM 4 - X0306 4 2021-03-01 0 0001477449 Teladoc Health, Inc. TDOC 0001726419 Verstraete Stephany C/O TELADOC HEALTH, INC. 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577 0 1 0 0 Chief Marketing Officer Common Stock 2021-03-01 4 M 0 3169 A 16445 D Common Stock 2021-03-01 4 M 0 6031 22.30 A 22476 D Common Stock 2021-03-01 4 M 0 969 38.55 A 23445 D Common Stock 2021-03-01 4 S 0 7000 227 D 16445 D Common Stock 2021-03-02 4 S 0 1547 224.282 D 14898 D Common Stock 2021-03-02 4 M 0 1807 A 16705 D Common Stock 2021-03-02 4 M 0 3072 A 19777 D Restricted Stock Units 2021-03-01 4 M 0 3169 0 D Common Stock 3169 0 D Employee Stock Option (right to buy) 22.30 2021-03-01 4 M 0 6031 0 D 2027-03-03 Common Stock 6031 6569 D Employee Stock Option (right to buy) 38.55 2021-03-01 4 M 0 969 0 D 2028-03-01 Common Stock 969 46331 D Restricted Stock Units 2021-03-02 4 M 0 1807 0 D Common Stock 1807 3615 D Performance Stock Units 2021-03-02 4 A 0 9218 0 A Common Stock 9218 9218 D Performance Stock Units 2021-03-02 4 M 0 3072 0 D Common Stock 3072 6146 D Restricted Stock Units 2021-03-02 4 A 0 3442 0 A Common Stock 3442 3442 D Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Performance stock units convert to shares of TDOC common stock on a one-for-one basis. On March 1, 2018, the reporting person was granted 9,507 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vested in 36 equal monthly installments thereafter. The option vested as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. On March 2, 2020, the reporting person was granted 5,422 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Each performance stock unit represents a contingent right to receive one share of TDOC common stock. Performance award amount determined based on metrics in respect of the issuer's 2020 financial results. The performance stock units vest in three substantially equal annual installments beginning on March 2, 2021. On March 2, 2021, the reporting person earned 9,218 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. The restricted stock units vest in three substantially equal annual installments beginning on the first anniversary of the grant date. /s/ Adam C. Vandervoort, attorney-in-fact 2021-03-03